Skip to main content
. 2015 Aug 18;7(6):1151–1160. doi: 10.1080/19420862.2015.1081323

Table 3.

Apparent KD of canakinumab for human and marmoset IL-1β

  kon [105/Ms] koff [10−5/s] KD [pM]  
Human IL-1β 11.0 ± 0.24 3.30 ± 0.29 30.5 ± 2.6 n=22
Marmoset IL-1β 15.4 ± 0.37 3.46 ± 0.35 22.8 ± 2.5 n=20

Association (kon) and dissociation (koff) rate constants and equilibrium binding constant (KD) were determined by surface plasmon resonance. Values represent mean ± SD (standard deviation), n denotes the number of independent evaluations.